Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 108

Similar articles for PubMed (Select 17896892)

1.

Mortality reduction benefits of a comprehensive cardiac care program for patients with occlusive coronary artery disease.

Merenich JA, Olson KL, Delate T, Rasmussen J, Helling DK, Ward DG; Clinical Pharmacy Cardiac Risk Service Study Group.

Pharmacotherapy. 2007 Oct;27(10):1370-8.

PMID:
17896892
2.

Development of a charge adjustment model for cardiac catheterization.

Brennan A, Gauvreau K, Connor J, O'Connell C, David S, Almodovar M, DiNardo J, Banka P, Mayer JE Jr, Marshall AC, Bergersen L.

Pediatr Cardiol. 2015 Feb;36(2):264-73. doi: 10.1007/s00246-014-0994-3. Epub 2014 Aug 12.

3.

Relation of body mass index to mortality among Asian patients with obstructive coronary artery disease during a 10-year follow-up: a report from the ET-CHD registry.

Lin GM, Li YH, Lin CL, Wang JH, Han CL.

Int J Cardiol. 2013 Sep 20;168(1):616-20. doi: 10.1016/j.ijcard.2013.01.204. Epub 2013 Mar 7. No abstract available.

PMID:
23465238
4.

Blood pressure level attainment among patients with coronary artery disease and uncontrolled blood pressure.

McConnell KJ, Morris JL, Delate T, Cymbala AA, Hornak R, Kauffman AB, McGinnis BD; Clinical Pharmacy Cardiac Risk Service Study Group.

Pharmacotherapy. 2011 Nov;31(11):1063-72. doi: 10.1592/phco.31.11.1063.

PMID:
22026394
5.
6.

Public policy action and CCC implementation: benefits and hurdles.

Steger C, Daniel K, Gurian GL, Petherick JT, Stockmyer C, David AM, Miller SE.

Cancer Causes Control. 2010 Dec;21(12):2041-8. doi: 10.1007/s10552-010-9668-5. Epub 2010 Nov 18. Review.

7.

Reduced health care expenditures after enrollment in a collaborative cardiac care service.

Delate T, Olson KL, Rasmussen J, Hutka K, Sandhoff B, Hornak R, Merenich J; Clinical Pharmacy Cardiac Risk Service Study Group.

Pharmacotherapy. 2010 Nov;30(11):1127-35. doi: 10.1592/phco.30.11.1127.

PMID:
20973686
8.

The CCC National Partnership: an example of organizations collaborating on comprehensive cancer control.

Hohman K, Rochester P, Kean T, Belle-Isle L.

Cancer Causes Control. 2010 Dec;21(12):1979-85. doi: 10.1007/s10552-010-9644-0. Epub 2010 Sep 26. Review.

PMID:
20872239
9.

The effect of drug vintage on survival: micro evidence from Puerto Rico's Medicaid program.

Lichtenberg FR.

Adv Health Econ Health Serv Res. 2010;22:273-92.

PMID:
20575237
10.

The Swiss National Cohort: a unique database for national and international researchers.

Spoerri A, Zwahlen M, Egger M, Bopp M.

Int J Public Health. 2010 Aug;55(4):239-42. doi: 10.1007/s00038-010-0160-5. No abstract available.

PMID:
20556473
11.

Statin adherence and mortality in patients enrolled in a secondary prevention program.

McGinnis BD, Olson KL, Delate TM, Stolcpart RS.

Am J Manag Care. 2009 Oct;15(10):689-95.

12.

Impact of reduced renal function on prognosis in Japanese patients with coronary artery disease: a prospective cohort of Shinken Database 2007.

Nakamura M, Yamashita T, Yajima J, Oikawa Y, Ogasawara K, Kirigaya H, Sagara K, Koike A, Sawada H, Aizawa T.

Hypertens Res. 2009 Oct;32(10):920-6. doi: 10.1038/hr.2009.114. Epub 2009 Aug 21.

PMID:
19696780
13.

Outcomes of patients discharged from pharmacy-managed cardiovascular disease management.

Olson KL, Delate T, Rasmussen J, Humphries TL, Merenich JA; Clinical Pharmacy Cardiac Risk Service Study Group.

Am J Manag Care. 2009 Aug;15(8):497-503.

14.

Predictors of 30-day and 1-year mortality after primary percutaneous coronary intervention for ST-elevation myocardial infarction.

Rasoul S, Ottervanger JP, de Boer MJ, Dambrink JH, Hoorntje JC, Marcel Gosselink AT, Zijlstra F, Suryapranata H, van 't Hof AW; Zwolle Myocardial Infarction Study Group.

Coron Artery Dis. 2009 Sep;20(6):415-21. doi: 10.1097/MCA.0b013e32832e5c4c.

PMID:
19641460
15.

Factors associated with recurrent coronary events among patients with cardiovascular disease.

McConnell KJ, Olson KL, Delate T, Merenich JA; Clinical Pharmacy Cardiac Risk Service Study Group.

Pharmacotherapy. 2009 Aug;29(8):906-13. doi: 10.1592/phco.29.8.906.

PMID:
19637943
16.

Clinical impact of early clopidogrel discontinuation following acute myocardial infarction hospitalization or stent implantation: analysis in a nationally representative managed-care population.

Wiederkehr D, Ogbonnaya A, Casciano R, Makenbaeva D, Mozaffari E, Corbelli J.

Curr Med Res Opin. 2009 Sep;25(9):2327-34. doi: 10.1185/03007990903156087.

PMID:
19635046
17.

Clinical impact of early clopidogrel discontinuation following acute myocardial infarction hospitalization or stent implantation: analysis in a single integrated health network.

Wiederkehr D, Berenson K, Casciano R, Stern L, Makenbaeva D, Mozaffari E, Lamerato L, Corbelli J.

Curr Med Res Opin. 2009 Sep;25(9):2317-25. doi: 10.1185/03007990903156061.

PMID:
19635042
18.

Low incidence of cardiac events in statin-administered patients in CAG study.

Saeki T, Sakuma N, Hayakawa K, Itou K, Wakami K, Tamai N, Kimura G.

J Atheroscler Thromb. 2009 Jun;16(3):172-8. Epub 2009 Jun 25.

19.

Twelve months clinical outcome of drug-eluting stents implantation or coronary artery bypass surgery for the treatment of diabetic patients with multivessel disease.

Qiao Y, Ma C, Nie S, Liu X, Kang J, Lv Q, Du X, Hu R, Zhang Y, Jia C, Liu X, Dong J, Chen F, Zhou Y, Lv S, Huang F, Gu C, Wu X.

Clin Cardiol. 2009 Aug;32(8):E24-30. doi: 10.1002/clc.20413.

PMID:
19455692
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk